Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
419.00    -3.00 (-0.71%)
Bid:
420.50
Ask:
422.00
Spread: 1.50 (0.357%)
Market Cap: £206.07m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

8 Jul 2013 07:00

RNS Number : 7580I
Zotefoams PLC
08 July 2013
 



8 July 2013

 

 

 

Zotefoams plc

("Zotefoams" or "the Company")

 

 

Trading Update

 

 

8 July 2013 - Zotefoams, which manufactures and sells high-performance foams, today announces its trading update for the first six months ended 30 June 2013.

 

Since our AGM and Interim Management Statement on 15 May 2013 the Company has experienced improved overall trading with a good level of sales in the final two months of the half year ended 30 June 2013. This has been driven in particular by growth in our High-Performance Polymers ("HPP") and MuCell Extrusion LLC ("MEL") businesses.

 

In the period to 30 June 2013 sales in our Azote® polyolefin business were below what was a very strong comparative period last year. Primarily this is due to customer destocking, most evident in Germany and Japan coincident with improvements in our order lead times, and a lower underlying level of sales in continental Europe.

 

The price of our main raw material, LDPE (low density polyethylene), eased in April and May so that the average Euro price for the period was similar to that in the first six months of 2012. Compared with the same period, currency rates for the US dollar and Euro have remained beneficial for our export-led business.

 

Overall sales growth in HPP and MEL has not fully offset the lower level of sales in our Azote® polyolefin foams business, particularly in the earlier part of the period and in continental Europe. This will result in a profit for the first half of 2013 below that of a strong first half in 2012.

 

We continue to invest to support future growth across the portfolio of our activities and, while being mindful of near-term economic conditions, the Board remains confident about the long-term prospects for our business.

 

The Company expects to announce its interim results for the six months ended 30 June 2013 and provide an update on current trading on Tuesday, 6 August 2013.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0207-831-3113

John Dineen, Victoria Foster Mitchell

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

 

Cautionary statement regarding forward-looking statements

This document may contain forward-looking statements which are made in good faith and are based on current expectations or beliefs, as well as assumptions about future events. You can sometimes, but not always, identify these statements by the use of a date in the future or such words as "will", "anticipate", "estimate", "expect", "project", "intend", "plan", "should", "may", "assume" and other similar words. By their nature, forward-looking statements are inherently predictive and speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. You should not place undue reliance on these forward-looking statements, which are not a guarantee of future performance and are subject to factors that could cause our actual results to differ materially from those expressed or implied by these statements. The Company undertakes no obligation to update any forward-looking statements contained in this document, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMGGNNKGGFZM
Date   Source Headline
12th Jun 20192:53 pmRNSDirector/PDMR Shareholding
4th Jun 20193:44 pmRNSHolding(s) in Company
4th Jun 20193:06 pmRNSDirector/PDMR Shareholding
28th May 201911:54 amRNSHolding(s) in Company
28th May 20199:38 amRNSHolding(s) in Company
21st May 20195:36 pmRNSDirector/PDMR Shareholding
21st May 201912:20 pmRNSHolding(s) in Company
20th May 20197:00 amRNSHolding(s) in Company
16th May 201912:46 pmRNSDirector/PDMR Shareholding
15th May 20193:51 pmRNSResult of AGM
15th May 20197:00 amRNSTrading Update
7th May 20199:11 amRNSDirector Declaration
25th Apr 20194:40 pmRNSDirector/PDMR Shareholding
17th Apr 20192:35 pmRNS2018 Annual Report and Notice of the 2019 AGM
16th Apr 20194:41 pmRNSDirector/PDMR Shareholding
12th Apr 20193:54 pmRNSDirector/PDMR Shareholding
4th Apr 201911:01 amRNSHolding(s) in Company
29th Mar 201912:57 pmRNSHolding(s) in Company
22nd Mar 20192:21 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
18th Mar 20194:12 pmRNSHolding(s) in Company
14th Mar 201911:46 amRNSDirector/PDMR Shareholding
5th Mar 20195:55 pmRNSDirector Declaration
14th Feb 20195:02 pmRNSDirector/PDMR Shareholding
28th Jan 20195:09 pmRNSHolding(s) in Company
28th Jan 20197:00 amRNSNotice of Results
15th Jan 20195:08 pmRNSDirector/PDMR Shareholding
15th Jan 20192:06 pmRNSHolding(s) in Company
9th Jan 20193:48 pmRNSHolding(s) in Company
7th Jan 201911:41 amRNSHolding(s) in Company
7th Jan 201911:37 amRNSHolding(s) in Company
7th Jan 201910:37 amRNSHolding(s) in Company
7th Jan 201910:33 amRNSHolding(s) in Company
19th Dec 20189:11 amRNSHolding(s) in Company
13th Dec 20181:16 pmRNSDirector/PDMR Shareholding
10th Dec 20187:00 amRNSHolding(s) in Company
27th Nov 20185:26 pmRNSHolding(s) in Company
19th Nov 20185:37 pmRNSHolding(s) in Company
13th Nov 201812:36 pmRNSDirector/PDMR Shareholding
8th Nov 20187:30 amRNSHolding(s) in Company
7th Nov 201812:50 pmRNSHolding(s) in Company
1st Nov 20187:00 amRNSTrading Update
12th Oct 20185:06 pmRNSDirector/PDMR Shareholding
12th Sep 20184:14 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:34 pmRNSHolding(s) in Company
22nd Aug 20182:05 pmRNSHolding(s) in Company
15th Aug 201811:59 amRNSHolding(s) in Company
15th Aug 201811:53 amRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSInterim Results
25th Jul 20182:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.